doi: 10.3892/ijo.2017.4185 76
This translates to fewer medication adjustments, better adherence, and ultimately superior weight loss outcomes
Jacqueline Maya, M.D., from Massachusetts General Hospital-Mass General Brigham in Boston, and colleagues conducted a retrospective cohort study of 149,790 singleton pregnancies delivered between June 1, 2016, and March 31, 2025, to compare weight gain and pregnancy outcomes with and without exposure to GLP-1 RAs before or during early pregnancy
GLP-1 receptor agonists, including semaglutide, have been associated with acute pancreatitis in postmarketing surveillance, though a definitive causal relationship has not been established
Co-lyophilisation fixes it